MICIT
LIVE

Serial Number

98200315

Owner

BioNTech SE

Attorney

Monica Riva Talley

Filing Date

Sep 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MICIT Trademark

Serial Number: 98200315

MICIT is a trademark filed by BioNTech SE on September 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

BioNTech SE (46 trademarks)

An der Goldgrube 12

Entity Type: 94

Trademark Details

Filing Date

September 27, 2023

Registration Date

Not Registered

Published for Opposition

July 2, 2024

Goods & Services

Medical devices, namely, high-throughput analysis devices for next-generation sequencing for gene expression profiling and for the detection of epigenetic changes

Medical, veterinary and pharmaceutical consultancy, in particular with regard to the selection of suitable therapies for all types of cancer; Medical services, namely, conducting analyzes and treatments in the field of personalized cancer immunotherapy; Medical services, namely, providing nucleic acid based therapies and checkpoint inhibitors

Scientific apparatus and instruments, namely, downloadable mobile software applications for personalized cancer patient information; Software algorithms, namely, downloadable software programs for detecting and registering mutations in cancer patients

Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and/or proteins; Medicines individually tailored for the respective patient, in particular based on nucleic acids and proteins, namely, pharmaceutical preparations for treatment of cancer

Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and therapy using molecular biological, genetic engineering, biotechnological and/or bioinformatic methods, in particular using next-generation sequencing; Scientific laboratory services and scientific research for medical purposes in the field of oncology, namely, diagnostics of tumor markers for personalized therapy

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 15, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 14, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 14, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 14, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 13, 2025 EXRA
SOU EXTENSION 2 GRANTED
Aug 12, 2025 EX2G
SOU EXTENSION 2 FILED
Aug 12, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 9, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 9, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 9, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 27, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 28, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 28, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 28, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 28, 2024 CNEA
ASSIGNED TO EXAMINER
May 20, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 11, 2023 NWOS
NEW APPLICATION ENTERED
Sep 30, 2023 NWAP